The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism
Open accessAbstract
Among the pathogenic processes contributing to dopaminergic neuron (DN) death in Parkinson disease (PD), evidence points to non-cell-autonomous mechanisms, particularly chronic inflammation mounted by activated microglia. Yet little is known about endogenous regulatory processes that determine microglial actions in pathological states. We examined the role of glucocorticoid receptors (GRs), activated by glucocorticoids released in response to stress and known to regulate inflammation, in DN survival. Overall GR level was decreased in substantia nigra of PD patients and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-intoxicated mice. GR changes, specifically in the microglia after MPTP treatment, revealed a rapid augmentation in the number of microglia displaying nuclear localization of GR. Mice with selective inactivation of the GR gene in macrophages/microglia (GR(LysMCre)) but not in DNs (GR(DATCre)) showed increased loss of DNs after MPTP intoxication. This DN loss in GR(LysMCre) mice was not prevented by corticosterone treatment, in contrast to the protection observed in control littermates. Moreover, absence of microglial GRs augmented microglial reactivity and led to their persistent activation. Analysis of inflammatory genes revealed an up-regulation of Toll-like receptors (TLRs) by MPTP treatment, particularly TLR9, the level of which was high in postmortem parkinsonian brains. The regulatory control of GR was reflected by higher expression of proinflammatory genes (e.g., TNF-α) with a concomitant decrease in anti-inflammatory genes (e.g., IL-1R2) in GR(LysMCre) mice. Indeed, in GR(LysMCre) mice, alterations in phosphorylated NF-κB levels indicated its protracted activation. Together, our data indicate that GR is important in curtailing microglial reactivity, and its deregulation in PD could lead to sustained inflammation-mediated DN injury.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“TLR9 was found to be overexpressed in the substantia nigra and putamen of PD patients and in striatum of a PD mouse model,316”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [316]
In the citing paper
“Upon MPTP intoxication (115) or intra-striatal injection of LPS (116), this strain exhibited greater neuronal loss, microglia reactivity, and expression of pro-inflammatory genes than age-matched controls.”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [115]
Citations
Cites
Dauer, W., & Przedborski, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00568-3 · Cited by 5,469
Brain corticosteroid receptor balance in health and disease
de Kloet, E. R., Vreugdenhil, E., Oitzl, M. S., & Joëls, M. (1998) · Endocrine Reviews · doi:10.1210/edrv.19.3.0331 · Cited by 2,614
Conditional gene targeting in macrophages and granulocytes using LysMcre mice
Clausen, B. E., Burkhardt, C., Reith, W., Renkawitz, R., & Förster, I. (1999) · Transgenic Research · doi:10.1023/a:1008942828960 · Cited by 2,098
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Self-citationControl of microglial neurotoxicity by the fractalkine receptor
Cardona, A. E., Pioro, E. P., Sasse, M. E., Kostenko, V., Cardona, S. M., Dijkstra, I. M., Huang, D., Kidd, G., Dombrowski, S., Dutta, R., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1715 · Cited by 1,531
Shaping the nuclear action of NF-κB
Chen, L., & Greene, W. C. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1368 · Cited by 1,248
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 2×
“However, by day 7, this activation had declined (in mutants and controls), an observation in accordance with past studies (22).”
BackgroundResultSaijo, K., Winner, B., Carson, C. T., Collier, J. G., Boyer, L., Rosenfeld, M. G., Gage, F. H., & Glass, C. K. (2009) · Cell · doi:10.1016/j.cell.2009.01.038 · Cited by 957
Microglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 869
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Cited by
Sorted by citations
Items 201–230 of 230
Bi-directional interaction of NF-κB in nervous system damage, learning and memory
Liu, Q. F., Yang, Z., li, J. C., Wang, S. R., Wang, X., & Hao, S. L. (2012) · Neurology Psychiatry and Brain Research · doi:10.1016/j.npbr.2012.05.001
Neuroinflamação na doença de Parkinson
Sousa, A. A. D., Braga, S. A., & Sobrinho, H. M. D. R. (2016) · Revista Estudos - Revista de Ciências Ambientais e Saúde (EVS) · doi:10.18224/est.v43i1.5188
Targeting the Gut-Brain axis in Parkinson's disease
Perez‐Pardo, P. (2017) · Utrecht University Repository (Utrecht University)
An Overview for Possible Mechanisms Governing Stress-induced Microglial Activation
Sugama, S., & Kakinuma, Y. (2019) · Nihon Ika Daigaku Igakkai Zasshi · doi:10.1272/manms.15.96
Mikroglial Toll-benzeri Reseptörlerin Alzheimer ve Parkinson Hastalıklarındaki Rolü
Samur, D. N., & Özbey, G. (2021) · Akdeniz Medical Journal · doi:10.53394/akd.981907
Sánchez-Petidier, M. (2022) · RiuNet (Universitat Politècnica de València) · doi:10.4995/thesis/10251/180753
Loike, J. D., Jackson-Lewis, V. R., & Przedborski, S. (2016) · Springer eBooks · doi:10.1007/978-3-319-44022-4_31
Rungruang, P., Sansri, V., & Sroyraya, M. (2024) · Neuroscience Research Notes · doi:10.31117/neuroscirn.v7i1.271
Yadav, R., Mani, R. J., Kumar, A. H. S., Ahmad, S., & Katare, D. P. (2024) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2990 · Cited by 1
Cross-talk between genetic and environmental factors in Parkinson's disease
Fernagut, P., & Dehay, B. (2025) · Handbook of behavioral neuroscience · doi:10.1016/b978-0-443-21992-4.00001-4
Modulation of microglia-T cell interaction as treatment of Parkinson's disease
Szklany, K. (2013) · Utrecht University Repository (Utrecht University)
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734887
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734896
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734893
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734905
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734908
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734890
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734863
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734866
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734899
Nakos‐Bimpos, M., Karali, K., Antoniou, C., Palermos, D., Fouka, M., Delis, A. D., Tzieras, I., Chrousos, G. P., Koutmani, Y., Stefanis, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26734902
Zheng, B., Zhang, N., Hu, M., Zhou, Y., Zhang, Z., You, Y., Xiao, C., Zhao, Q., Feng, S., Wang, X. R., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2025.116820
Étude moléculaire de l'inflammation chronique dans la maladie de Parkinson
Compagnion, A. (2019) · theses.fr (ABES) · doi:10.70675/04ca138dz3131z4e24z884czbba2f7954a99
Chronic stress and glucocorticoid actions in brain plasticity and Tau pathology
Dioli, C. (2021) · theses.fr (ABES) · doi:10.70675/b812791ezcc0az4036zb746z0d9b5daacfab
Depression and the Immune Responses
Sunzeri, F. (2026) · Springer eBooks · doi:10.1007/978-3-032-14465-2_10
Xu, L., Xiao, K., Jiang, J., Tang, Y., Yang, L., Xiao, S., Jin, X., Xiao, B., Zhou, T., Hao, C., et al. (2026) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2026.120715
Slayden, R. A., Tjalkens, R. B., Theise, N. D., Verrico, C. D., Azevedo, E. P., Drie, J. H. V., Bardo, M. T., Prendergast, M., Butt, C. M., Altschul, R., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1931270
Metadata
- Authors
- Ros-Bernal, F., Hunot, S., Herrero, M. T., Parnadeau, S., Corvol, J.-C., Lu, L., Alvarez-Fischer, D., Carrillo-de Sauvage, M. A., Saurini, F., Coussieu, C., Kinugawa, K., Prigent, A., Höglinger, G., Hamon, M., Tronche, F., Hirsch, E. C., & Vyas, S.
- Affiliations
- Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 7224, F-75005 Paris, France;
- Centre National de la Recherche Scientifique (FR)
- Clinical and Experimental Neuroscience, Centro de Investigación Biomedica en Red de Enfermedades Neurodegenerativas (CIBERNED), School of Medicine, University of Murcia, 30100 Murcia, Spain;
- Université Pierre et Marie Curie–Paris 06, F-75252 Paris Cedex 5, France;
- Inserm (FR)
- Pitié-Salpêtrière Hospital (FR)
- Philipps University of Marburg (DE)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2011-04-05
- Volume
- 108
- Issue
- 16
- Pages
- 6632-6637
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC3080980
- OpenAlex
- W2045465918
- Cited by
- 231
- References
- 33
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 20 · 2023: 7 · 2022: 11 · 2021: 22 · 2020: 10 · 2019: 17 · 2018: 14 · 2017: 15 · 2016: 17 · 2015: 20 · 2014: 16 · 2013: 16 · 2012: 21
- FWCI
- 10.60
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- mediaTUM (Technical University of Munich) (submittedVersion)
- Funders
- Institut National de la Santé et de la Recherche Médicale
- Fondation de France
- Centre National de la Recherche Scientifique
- Ministerio de Ciencia e Innovación
- Université Pierre et Marie Curie
- Association France Parkinson
- Topics
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Nuclear Receptors and Signaling
- Keywords
- glucocorticoid receptor, microglia, dopaminergic neuron loss, Parkinson's disease, MPTP-induced neurotoxicity, neuroinflammation, substantia nigra, TLR9, NF-κB signaling, corticosterone, microglial activation, TNF-α, IL1R2, non-cell autonomous neurodegeneration
- MeSH terms
- Aged, Aged, 80 and over, Animals, Cell Nucleus, Female, Humans, Inflammation, Male, Mice, Transgenic, Parkinson Disease, Receptors, Glucocorticoid, Substantia Nigra, Up-Regulation, Microglia, MPTP Poisoning, Toll-Like Receptors, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review